CHD/Prevention

Top Story

HPS2-THRIVE analysis: Adding niacin with laropiprant to statin reduced survival, increased costs

July 25, 2016

Quality of life-adjusted survival was reduced and hospital costs rose due to the addition of extended-release niacin with laropiprant to statin-based therapy, according to a new analysis of the HPS2-THRIVE study.

Researchers analyzed data from 25,673 patients aged 50 to 80 years with a history of MI, cerebrovascular disease, peripheral artery disease or diabetes with any evidence of symptomatic coronary disease from 245 hospitals in China, Denmark, Finland, Norway, Sweden and the United Kingdom.

FDA News

FDA denies AstraZeneca request to block approvals of generic rosuvastatin

July 22, 2016
The FDA has denied AstraZeneca’s citizen petition for a temporary restraining order to prevent approval of any abbreviated new drug applications for generic…
Meeting News Coverage

Upcoming conference highlights advances in lipidology

July 22, 2016
The National Lipid Association Clinical Lipid Update in August will feature keynote addresses from leading experts in the field, including Neil J. Stone, MD, FACC
In the Journals

Statin therapy lowers CAD, mortality risk in familial hypercholesterolemia

July 21, 2016
Moderate- to high-intensity statin therapy lowered the risk for CAD and mortality for patients with heterozygous familial hypercholesterolemia, according to findings…
CME

CARDIOVASCULAR CONSULTS®: Volume 1, Number 1

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Heart failure is a complex clinical syndrome that constitutes a major morbidity and mortality burden and stress on the…
More »
Video
Meeting News Coverage

VIDEO: SOLID-TIMI 52 substudy shows IL-6 independently predicts CV outcomes

June 15, 2016
More »
Featured
AAHFN 2016

AAHFN 2016

Video
Meeting News Coverage

VIDEO: Uric acid levels in patients with ACS suggest increased risk for CAD, represent predictive tool

July 6, 2016
More »
In the Journals

HPS2-THRIVE analysis: Adding niacin with laropiprant to statin reduced survival, increased costs

July 25, 2016
Quality of life-adjusted survival was reduced and hospital costs rose due to the addition of extended-release niacin with laropiprant to statin-based…

FDA News

FDA denies AstraZeneca request to block approvals of generic rosuvastatin

July 22, 2016
The FDA has denied AstraZeneca’s citizen petition for a temporary restraining order to prevent approval of any abbreviated new drug…

Meeting News Coverage

Upcoming conference highlights advances in lipidology

July 22, 2016
The National Lipid Association Clinical Lipid Update in August will feature keynote addresses from leading experts in the field, including Neil J

In the Journals

Statin therapy lowers CAD, mortality risk in familial hypercholesterolemia

July 21, 2016
Moderate- to high-intensity statin therapy lowered the risk for CAD and mortality for patients with heterozygous familial hypercholesterolemia…

Mediterranean diet can reduce health risks without fat intake restrictions

July 20, 2016
Without restricting fat intake, a Mediterranean diet may lower the occurrence of cardiovascular events, breast cancer, and type 2 diabetes, according…

Meeting News Coverage

Experts deliberate LDL cholesterol goals, statin adherence post-ACS

July 20, 2016
With the intensity of lipid-lowering therapy in high-risk patients after an ACS an ongoing clinical conundrum, two experts took center stage at the…

In the Journals

Various biomarkers associated with cardiac calcification in older adults

July 19, 2016
Researchers reported in Heart an association between certain biomarkers and mitral annular calcification or aortic valve calcification in older…

In the Journals

Risk for CV outcomes, all-cause death varies by DPP-IV, TZD use

July 19, 2016
In patients with type 2 diabetes, risk for cardiovascular disease, heart failure and all-cause mortality varies by diabetes drug classes, alone and…

In the Journals

Improved walking speed associated with reduced hospitalization rates

July 19, 2016
For cardiac outpatients, an increase of 1 km per hour in walking speed is associated with a 21% lower all-cause hospitalization rate, according to…

In the JournalsPerspective

INTERSTROKE: Modifiable risk factors may explain nine of 10 acute strokes

July 18, 2016
Ten modifiable risk factors, most importantly hypertension, account for approximately 90% of acute strokes worldwide, according to the INTERSTROKE…

More Headlines »